Explore how Siemens gPROMS digital twins can address key challenges in the pharmaceutical industry, including accelerating development timelines and modernizing knowledge transfer.
The pharmaceutical industry faces numerous challenges, with great urgency to accelerate development timelines, meet rapidly-changing global supply chain requirements, expand new molecule pipelines, and modernize knowledge transfer within the organization. In recent years, mechanistic modelling has gained traction in the pharmaceutical sector as a favoured approach for accelerating research, development and production. This strategy improves R&D efficiency, facilitates scale-up and technology transfer, and expedites time-to-market. In this webinar, Siemens gPROMS will be showcased as a key digitalization technology that is already delivering value across the industry.
Learn how digital twins can transform pharmaceutical R&D.